Shares Investor Evening - Webinar - 17 Sep 2020
Webinar
Thursday, September 17, 2020 - 06:00 PM
Until: Thursday, September 17, 2020 - 07:20 PM
(Adjusted for timezone: Europe/London)
Categories
Come online and join Shares and AJ Bell Media at their next webinar on Thursday 17 September 2020 which can be accessed from wherever you are!
Shares Spotlight webinars feature presentations from directors of listed companies explaining their investment propositions followed by an opportunity for you to ask questions. This is your chance to hear first-hand from the people making the decisions on what these companies do and how they are going to generate shareholder value.
Accessing the webinar is very simple; simply register your details and follow the link that you will receive in your confirmation email at the scheduled time of the webinar.
The webinar will not require your participation in the form of audio or video, however you will have the opportunity to ask questions to the presenters via an online chat window during the webinar.
The webinar will follow a similar format to our regular Shares Investor Evenings, and is open to any existing shareholders or potential investors.
The webinar will feature the following companies:
Belvoir Group (BLV) is the UK’s largest property franchise on the high street. We have over 170 offices around the UK managing a combined total of more than 30,000 properties – with a total value of over £10billion.
Diurnal Group (DNL) is a specialty pharmaceutical company developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.
Open Orphan (ORPH) is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Open Orphan comprises of two commercial specialist CRO services businesses; hVIVO and Venn Life Sciences and is actively involved in the fight against COVID-19.
Click on the REGISTER tab now to secure your place!
Who Should Attend
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Evening timings
18.00 Introduction
Roland Spencer, Head of Sales - Shares
18.05 Diurnal Group
Martin Whitaker, CEO - Diurnal (DNL)
18.30 Belvoir Group
Dorian Gonsalves, CEO - Belvoir Group (BLV)
18.55 Open Orphan
Cathal Friel, Executive Chairman - Open Orphan (ORPH)
19.20 End of event
For more information, visit https://www.sharesmagazine.co.uk/events/event/shares-investor-evening--webinar-170920
Shares Spotlight webinars feature presentations from directors of listed companies explaining their investment propositions followed by an opportunity for you to ask questions. This is your chance to hear first-hand from the people making the decisions on what these companies do and how they are going to generate shareholder value.
Accessing the webinar is very simple; simply register your details and follow the link that you will receive in your confirmation email at the scheduled time of the webinar.
The webinar will not require your participation in the form of audio or video, however you will have the opportunity to ask questions to the presenters via an online chat window during the webinar.
The webinar will follow a similar format to our regular Shares Investor Evenings, and is open to any existing shareholders or potential investors.
The webinar will feature the following companies:
Belvoir Group (BLV) is the UK’s largest property franchise on the high street. We have over 170 offices around the UK managing a combined total of more than 30,000 properties – with a total value of over £10billion.
Diurnal Group (DNL) is a specialty pharmaceutical company developing hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypogonadism and Hypothyroidism.
Open Orphan (ORPH) is a world leader in the testing of vaccines and antivirals through the use of human challenge clinical trials. Open Orphan comprises of two commercial specialist CRO services businesses; hVIVO and Venn Life Sciences and is actively involved in the fight against COVID-19.
Click on the REGISTER tab now to secure your place!
Who Should Attend
The evening exposes investors to companies across various sectors. Perfect for existing investors as well as those looking for new investment opportunities.
Evening timings
18.00 Introduction
Roland Spencer, Head of Sales - Shares
18.05 Diurnal Group
Martin Whitaker, CEO - Diurnal (DNL)
18.30 Belvoir Group
Dorian Gonsalves, CEO - Belvoir Group (BLV)
18.55 Open Orphan
Cathal Friel, Executive Chairman - Open Orphan (ORPH)
19.20 End of event
For more information, visit https://www.sharesmagazine.co.uk/events/event/shares-investor-evening--webinar-170920